---
layout: page
exclude: true
---

## Antimetabolites

> Mechanism of action:
>
> Inhibit the replication of DNA.

1. Cytidine analogs

| Name | Structure |
| :===: | :===: |
| Azacytidine | ![azacytidine](https://upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Azacitidine.svg/220px-Azacitidine.svg.png){:width="30%"}|
| Decitabine | ![decitabine](https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Decitabine.svg/220px-Decitabine.svg.png){:width="30%"} |
| Cytarabine | ![cytarabine](https://upload.wikimedia.org/wikipedia/commons/thumb/d/da/Cytarabin.svg/200px-Cytarabin.svg.png){:width="30%"}|
| Gemcitabine | ![gemcitabine](https://upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Gemcitabine.svg/155px-Gemcitabine.svg.png){:width="30%"}|



> MoA: Directly incorporate into DNA and inhibit DNA methyltransferase (azacitidine, decitabine) or DNA polymerase (cytarabine, gemcitabine)

* Indications: Azacitidine and decitabine for [MDS](https://en.wikipedia.org/wiki/Myelodysplastic_syndrome), [AML](https://en.wikipedia.org/wiki/Acute_myeloid_leukemia), cytarabineÂ for MDS, AML, and gemcitabine for breast, [NSCLC](https://en.wikipedia.org/wiki/Non-small-cell_lung_cancer), ovarian, pancreatic, bladder, sarcoma, [Hodkin lymphoma](https://en.wikipedia.org/wiki/Hodgkin_lymphoma), NHL
* Toxicity: Myelosuppression in general. Cytarabine high dose causes neurotoxicity, conjunctivitis. Gemcitabine causes liver enzyme elevations, interstitial pneumonitis.

2. Folate antagonists

| Name | Structure |
| :===: | :===: |
| Methotrexate | ![methotrexate](https://upload.wikimedia.org/wikipedia/commons/thumb/3/30/Methotrexate_skeletal.svg/300px-Methotrexate_skeletal.svg.png){:width="60%"}|
| Pemetrexed | ![pemetrexed](https://upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Pemetrexed.svg/220px-Pemetrexed.svg.png){:width="60%"} |

> MOA: Reduces folate, which is essential in the synthesis of purine nucleotides and thymidylate
* Indications: Methotrexate for ALL, NHL, CNS, sarcoma, and pemetrexed for malignant pleural mesothelioma, NSCLC (non-squamous)
* Toxicity: Myelosuppression, mucositis, hepatotoxicity, nephrotoxicity, cutaneous reactions
* Toxicity prevention: Hydration and alkalization of the urine, leucovorin rescue

* [PDB 7dfr](https://www.rcsb.org/structure/7dfr)
* [PDB 3dfr](https://www.rcsb.org/structure/3dfr)

3. Purine analogs

| Name | Structure |
| :===: | :===: |
| Cladribine | ![cladribine](https://upload.wikimedia.org/wikipedia/commons/thumb/7/7a/Cladribine.svg/200px-Cladribine.svg.png){:width="30%"}|
| Clofarabine | ![clofarabine](https://upload.wikimedia.org/wikipedia/commons/thumb/8/8b/Clofarabine.svg/220px-Clofarabine.svg.png){:width="30%"} |
| Nelarabine | ![nelarabine](https://upload.wikimedia.org/wikipedia/commons/thumb/6/63/Nelarabine_structure.svg/200px-Nelarabine_structure.svg.png){:width="30%"} |

> MOA: structural analogs of guanine and act as false metabolites
*   Indications: Cladribine for hairy cell leukemia, AML, CLL, NHL. Clofarabine for ALL, AML. fludarabine for CLL, AML, NHL, BMT conditioning agent. Nelarabine for T-ALL, lymphoma. Pentostatin for hairy cell leukemia, CTCL, CLL.
*  Toxicities: Myelosuppression, immunosuppression (suppress CD4+ cells) put patients at risk for opportunistic infections

4. Pyrimidine analogs

| Name | Structure |
| :===: | :===: |
| Fluorouracil (5-FU) | ![fluorouracil](https://upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Fluorouracil2DACS.svg/800px-Fluorouracil2DACS.svg.png){:width="30%"}|
| Capecitabine (prodrug of 5-FU) | ![capecitabine](https://upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Capecitabine.svg/280px-Capecitabine.svg.png){:width="30%"} |



> MOA: Active metabolite (F-dUMP) forms a stable covalent complex with thymidine synthetase in the presence of reduced folate, therefore, interfering with DNA synthesis and repair.
